Revelation Biosciences, Inc. (REVB)
1.42
+0.02
(+1.43%)
USD |
NASDAQ |
Feb 20, 16:00
1.45
+0.03
(+2.11%)
After-Hours: 20:00
Revelation Biosciences EPS Diluted (Quarterly) : -7.074 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SCWorx Corp. | -0.1545 |
| ImmunityBio, Inc. | -0.071 |
| Movano, Inc. | -4.734 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.907M |
| Total Expenses (Quarterly) | 1.907M |
| Enterprise Value | -10.61M |
| Earnings Yield | -6.83K% |
| Normalized Earnings Yield | -6834.56 |